Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy

Vaccine

Volumn 24, Issue 16, 2006, Pages 3095-3099

  Siriaksorn, Sudawan ^a   Puthanakit, Thanyawee ^a,b   Sirisanthana, Thira ^b   Sirisanthana, Virat ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Hepatitis B virus (HBV); Human immunodeficiency virus (HIV); Protective antibody

Indexed keywords

MARKER VACCINE; VIRUS ANTIBODY;

ARTICLE; FEMALE; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; MALE; RNA, VIRAL;

EID: 33645054030     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.045     Document Type: Article

References (22)

1. S. Singhal, and J. Mehta Reimmunization after blood or marrow stem cell transplantation Bone Marrow Transpl 23 7 1999 637 646
2. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000;49(RR-10):1-125, CE1-7.
3. S.K. Obaro, D. Pugatch, and K. Luzuriaga Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children Lancet Infect Dis 4 8 2004 510 518
4. A.L. Landay, D. Bettendorf, E. Chan, J. Spritzler, J.L. Schmitz, and R.P. Bucy Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease AIDS Res Hum Retrov 18 2 2002 95 102
5. W.J. Moss, C.J. Clements, and N.A. Halsey Immunization of children at risk of infection with human immunodeficiency virus Bull World Health Organ 81 1 2003 61 70 Epub 2003 March 11
6. S. Lolekha Hepatitis B in Thailand: epidemiology, prevention and control A. Zuckerman Hepatitis B in the Asian-Pacific region 1998 Royal College of Physicians of London London 13 19
7. Results of HIV Sero-surveillance, Thailand 1989-2004 (round 1-22) [Accessed at http://www.epid.moph.go.th/]
8. R.J. Gilson, A.E. Hawkins, M.R. Beecham, E. Ross, J. Waite, and M. Briggs Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection AIDS 11 5 1997 597 606
9. J. Horvath, and S.P. Raffanti Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses Clin Infect Dis 18 3 1994 339 347
10. Y. Poovorawan, A. Theamboonlers, T. Vimolket, S. Sinlaparatsamee, K. Chaiear, and T. Siraprapasiri Impact of hepatitis B immunisation as part of the EPI Vaccine 19 7-8 2000 943 949
11. M.P. Arrazola, J.R. de Juanes, J.T. Ramos, A.J. Aragon, and A. Garcia de Codes Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus J Med Virol 45 3 1995 339 341
12. R.M. Rutstein, B. Rudy, C. Codispoti, and B. Watson Response to hepatitis B immunization by infants exposed to HIV AIDS 8 9 1994 1281 1284
13. C. Scolfaro, P. Fiammengo, L. Balbo, E. Madon, and P.A. Tovo Hepatitis B vaccination in HIV-1-infected children: double efficacy doubling the paediatric dose AIDS 10 10 1996 1169 1170
14. P. Thaithumyanon, S. Punnahitananda, P. Praisuwanna, and U. Thisyakorn Ruxrungtham K. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers J Med Assoc Thai 85 3 2002 277 282
15. G. Zuin, N. Principi, R. Tornaghi, S. Paccagnini, M. Re, and E. Massironi Impaired response to hepatitis B vaccine in HIV-infected children Vaccine 10 12 1992 857 860
16. 1994 Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age. 1994 [Accessed at http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm].
17. J.A. Hochman, and W.F. Balistreri Chronic viral hepatitis: always be current! Pediatr Rev 24 12 2003 399 410
18. A.R. Zanetti, A. Mariano, L. Romano, R. D'Amelio, M. Chironna, and R.C. Coppola Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study Lancet 366 9494 2005 1379 1384
19. R.X. Wang, G.J. Boland, J. van Hattum, and G.C. de Gast Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination World J Gastroenterol 10 2 2004 260 263
20. B. Watson, D.J. West, A. Chilkatowsky, S. Piercy, and V.A. Ioli Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine Vaccine 19 23-24 2001 3164 3168
21. E.M. Tedaldi, R.K. Baker, A.C. Moorman, K.C. Wood, J. Fuhrer, and R.E. McCabe Hepatitis A and B vaccination practices for ambulatory patients infected with HIV Clin Infect Dis 38 10 2004 1478 1484
22. M.O. Fonseca, L.W. Pang, Nd.P. Cavalheiro, A.A. Barone, and M.H. Lopes Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose Vaccine 23 22 2005 2902 2908